Comments
Loading...

HCW Biologics

HCWBNASDAQ
$0.600000
-0.0010-0.17%
At Close: -
$0.679700
0.0813.28%
After Hours: Jul 19, 7:39 AM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$9.00
Lowest Price Target1
$4.00
Consensus Price Target1
$7.50

HCW Biologics (NASDAQ:HCWB) Stock, Analyst Ratings, Price Targets, Forecasts

HCW Biologics Inc has a consensus price target of $7.5 based on the ratings of 4 analysts. The high is $9 issued by EF Hutton on June 1, 2023. The low is $4 issued by Maxim Group on March 24, 2022. The 3 most-recent analyst ratings were released by EF Hutton on June 1, 2023, April 19, 2023, and March 30, 2023, respectively. With an average price target of $9 between EF Hutton, there's an implied 1224.11% upside for HCW Biologics Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

EF Hutton
EF Hutton
JonesTrading
Maxim Group

1calculated from analyst ratings

Analyst Ratings for HCW Biologics

Buy NowGet Alert
06/01/2023Buy Now1224.11%EF Hutton
Tony Butler
→ $9Assumes → BuyGet Alert
04/19/2023Buy Now1224.11%EF Hutton
Constantine Davides
→ $9Reiterates → BuyGet Alert
03/30/2023Buy Now1224.11%EF Hutton
Constantine Davides
→ $9Reiterates → BuyGet Alert
03/23/2023Buy Now1224.11%EF Hutton
Constantine Davides
→ $9Reiterates → BuyGet Alert
11/08/2022Buy Now1076.99%JonesTrading
Soumit Roy
→ $8Initiates → BuyGet Alert
03/24/2022Buy Now488.49%Maxim Group
Michael Okunewitch
→ $4Initiates → BuyGet Alert
11/19/2021Buy Now1371.24%EF Hutton
Constantine Davides
Initiates → BuyGet Alert

FAQ

Q

What is the target price for HCW Biologics (HCWB) stock?

A

The latest price target for HCW Biologics (NASDAQ:HCWB) was reported by EF Hutton on June 1, 2023. The analyst firm set a price target for $9.00 expecting HCWB to rise to within 12 months (a possible 1224.11% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for HCW Biologics (HCWB)?

A

The latest analyst rating for HCW Biologics (NASDAQ:HCWB) was provided by EF Hutton, and HCW Biologics their buy rating.

Q

When was the last upgrade for HCW Biologics (HCWB)?

A

There is no last upgrade for HCW Biologics

Q

When was the last downgrade for HCW Biologics (HCWB)?

A

There is no last downgrade for HCW Biologics.

Q

When is the next analyst rating going to be posted or updated for HCW Biologics (HCWB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HCW Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HCW Biologics was filed on June 1, 2023 so you should expect the next rating to be made available sometime around June 1, 2024.

Q

Is the Analyst Rating HCW Biologics (HCWB) correct?

A

While ratings are subjective and will change, the latest HCW Biologics (HCWB) rating was a with a price target of $0.00 to $9.00. The current price HCW Biologics (HCWB) is trading at is $0.68, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch